NCT06023368View on ClinicalTrials.gov

Reducing Port Access Pain and Clinic Wait Time: An Evaluation of EMLA Cream Versus nüm™ Vapocoolant Spray

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

December 23, 2023

Primary Completion Date

June 20, 2024

Study Completion Date

June 20, 2024

Conditions
Pediatric Cancer
Interventions
DRUG

Num Vapocoolant Spray

Spray applied around port prior to access

DRUG

EMLA Cream

cream applied around the port prior to access

Trial Locations (1)

40506

University of Kentucky DanceBlue Pediatric Hematology/oncology clinic, Lexington

Sponsors

Collaborators (1)

Bimeco Group
All Listed Sponsors
collaborator

Bimeco Group

UNKNOWN

lead

Marianne Hutti

OTHER

NCT06023368 - Reducing Port Access Pain and Clinic Wait Time: An Evaluation of EMLA Cream Versus nüm™ Vapocoolant Spray | Biotech Hunter | Biotech Hunter